CHALLENGES TO MAKE COST-EFFECTIVENESS STUDIES USABLE BY DECISION MAKERS
- 1 November 2018
- journal article
- letter
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 156 (5), 1931-1932
- https://doi.org/10.1016/j.jtcvs.2018.05.062
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The value and generalizability of cost-effectiveness researchThe Journal of Thoracic and Cardiovascular Surgery, 2018
- Exploring the support for high performance applications in the container runtime environmentHuman-centric Computing and Information Sciences, 2018
- Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost–benefit analysisPLOS ONE, 2017
- Recent amendments to NICE’s value-based assessment of health technologies: implicitly inequitable?Expert Review of Pharmacoeconomics & Outcomes Research, 2017
- A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?PLOS ONE, 2015
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) StatementValue in Health, 2013
- Is the QALY blind, deaf and dumb to equity? NICE's considerations over equityBritish Medical Bulletin, 2012
- QALYs: Some ChallengesValue in Health, 2009
- Welfarism, extra-welfarism and capability: The spread of ideas in health economicsSocial Science & Medicine (1982), 2008